Literature DB >> 1138881

Purification and properties of the anticoagulant principle of Trimeresurus gramineus venom.

C Ouyang, F Y Yang.   

Abstract

By means of DEAE-Sephadex A-50 column chromatography, Trimeresurus gramineus venom was separated into 12 fractions. Fraction 8 had marked anticoagulant action in the tests of whole blood clotting time, calcium clotting time and plasma prothrombin time. Fraction 8 was rechromatographed on Sephadex G-100, then on DEAE-Sephadex A-50 again, and finally on Sephadex G-100, and a single peak was obtained. The patterns of microzone and disc electrophoresis also showed a single band. A single symmetrical boundary with 1.70 Svedberg units was obtained by ultracentrifugation. The estimated molecular weight was 19 500. The isoelectric point was pH 4.5. Chemical analysis showed that the anticoagulant principle was a glycoprotein and that it was thermolabile. The anticoagulant activity of this purified principle was 3.5 times higher than that of the crude venom. Fraction 5 potentiated its anticoagulant activity to 10 times higher than that of the crude venom. This principle did not possess caseinolytic, tosyl-L-arginine methyl ester esterase, phospholipase A, phosphodiesterase, alkaline phosphomonoesterase, fibrinolytic, hemorrhagic or local irritating activities. The purified anticoagulant principle did not destroy fibrinogen, induce fibrinolysis, inactivate thrombin nor interfere with the interaction between thrombin and fibrinogen. However, a marked inhibition of prothrombin activation was caused by the anticoagulant principle. The inhibition of prothrombin activation was not due to the destruction of prothrombin or its activation factors, but due to an interference in the interaction between prothrombin and its activation factors because of the reversible binding of these factors with the anticoagulant principle of the venom.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1138881     DOI: 10.1016/0005-2795(75)90291-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

Review 1.  Anticoagulant proteins from snake venoms: structure, function and mechanism.

Authors:  R Manjunatha Kini
Journal:  Biochem J       Date:  2006-08-01       Impact factor: 3.857

2.  Envenomation by Trimeresurus stejnegeri stejnegeri: clinical manifestations, treatment and associated factors for wound necrosis.

Authors:  Liao-Chun Chiang; Wei-Jen Tsai; Po-Yu Liu; Cheng-Hsuan Ho; Hung-Yuan Su; Chih-Sheng Lai; Kuo-Lung Lai; Wen-Loung Lin; Chi-Hsin Lee; Yi-Yuan Yang; Uyen Vy Doan; Tri Maharani; Yan-Chiao Mao
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2020-09-18

3.  Envenoming by Viridovipera stejnegeri snake: a patient with liver cirrhosis presenting disruption of hemostatic balance.

Authors:  Chih-Ying Chien; Shu-Chen Liao; Chien-Hung Liao; Ting-Shuo Huang; Yu-Hsien Chen
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-02-14

Review 4.  Snake Venoms in Drug Discovery: Valuable Therapeutic Tools for Life Saving.

Authors:  Tarek Mohamed Abd El-Aziz; Antonio Garcia Soares; James D Stockand
Journal:  Toxins (Basel)       Date:  2019-09-25       Impact factor: 4.546

Review 5.  Bioactive Molecules Derived from Snake Venoms with Therapeutic Potential for the Treatment of Thrombo-Cardiovascular Disorders Associated with COVID-19.

Authors:  Fatah Chérifi; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2021-09-09       Impact factor: 2.371

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.